New Orleans - Topical imiquimod (Aldara) treatment may play a role in preventing UVB-induced cutaneous immunosuppression, Anthony A. Gaspari, M.D., said at the annual meeting of the American Academy of Dermatology.
The Weekly Roundup: November 26-December 1
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients
Reviewing Dermatologic Manifestations of HIV Infection and Acquired Immunodeficiency Syndrome
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium
Dual-Wavelength Laser Technology Demonstrates Promise in Atrophic Acne Scar Management
Samsung Bioepis Receives US License Date for Proposed Ustekinumab Biosimilar, SB17